- Motley Fool•4 days ago
Biogen's list price for a new rare-disease drug makes it one of the world's most expensive. Was that a mistake?
- Zacks•5 days ago
Ionis Pharmaceuticals, Inc. (IONS) is scheduled to report fourth-quarter 2016 results on Feb 28.
- Motley Fool•10 days ago
Here's what makes the pipelines of Celgene, Ionis, and Ligand among the best of all biotechs.
Requested symbol wasn't found